Cargando…

Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis

Objective: To investigate whether the dynamic contrast-enhanced ultrasound (DCE-US) analysis and quantitative parameters could be helpful for predicting histopathologic grades of pancreatic neuroendocrine tumors (pNETs). Methods: This retrospective study conducted a comprehensive review of the CEUS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dao-Hui, Cheng, Juan, Tian, Xiao-Fan, Zhang, Qi, Yu, Ling-Yun, Qiu, Yi-Jie, Lu, Xiu-Yun, Lou, Wen-Hui, Dong, Yi, Wang, Wen-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858178/
https://www.ncbi.nlm.nih.gov/pubmed/36673048
http://dx.doi.org/10.3390/diagnostics13020238
_version_ 1784874033956782080
author Yang, Dao-Hui
Cheng, Juan
Tian, Xiao-Fan
Zhang, Qi
Yu, Ling-Yun
Qiu, Yi-Jie
Lu, Xiu-Yun
Lou, Wen-Hui
Dong, Yi
Wang, Wen-Ping
author_facet Yang, Dao-Hui
Cheng, Juan
Tian, Xiao-Fan
Zhang, Qi
Yu, Ling-Yun
Qiu, Yi-Jie
Lu, Xiu-Yun
Lou, Wen-Hui
Dong, Yi
Wang, Wen-Ping
author_sort Yang, Dao-Hui
collection PubMed
description Objective: To investigate whether the dynamic contrast-enhanced ultrasound (DCE-US) analysis and quantitative parameters could be helpful for predicting histopathologic grades of pancreatic neuroendocrine tumors (pNETs). Methods: This retrospective study conducted a comprehensive review of the CEUS database between March 2017 and November 2021 in Zhongshan Hospital, Fudan University. Ultrasound examinations were performed by an ACUSON Sequioa unit equipped with a 3.5 MHz 6C−1 convex array transducer, and an ACUSON OXANA2 unit equipped with a 3.5 MHz 5C−1 convex array transducer. SonoVue(®) (Bracco Inc., Milan, Italy) was used for all CEUS examinations. Time intensity curves (TICs) and quantitative parameters of DCE-US were created by Vuebox(®) software (Bracco, Italy). Inclusion criteria were: patients with histopathologically proved pNETs, patients who underwent pancreatic B-mode ultrasounds (BMUS) and CEUS scans one week before surgery or biopsy and had DCE-US imaging documented for more than 2 min, patients with solid or predominantly solid lesions and patients with definite diagnosis of histopathological grades of pNETs. Based on their prognosis, patients were categorized into two groups: pNETs G1/G2 group and pNETs G3/pNECs group. Results: A total of 42 patients who underwent surgery (n = 38) or biopsy (n = 4) and had histopathologically confirmed pNETs were included. According to the WHO 2019 criteria, all pNETs were classified into grade 1 (G1, n = 10), grade 2 (G2, n = 21), or grade 3 (G3)/pancreatic neuroendocrine carcinomas (pNECs) (n = 11), based on the Ki−67 proliferation index and the mitotic activity. The majority of the TICs (27/31) of pNETs G1/G2 were above or equal to those of pancreatic parenchyma in the arterial phase, but most (7/11) pNETs G3/pNECs had TICs below those of pancreatic parenchyma from arterial phase to late phase (p < 0.05). Among all the CEUS quantitative parameters of DCE-US, values of relative rise time (rPE), relative mean transit time (rmTT) and relative area under the curve (rAUC) were significantly higher in pNETs G1/G2 group than those in pNETs G3/pNECs group (p < 0.05). Taking an rPE below 1.09 as the optimal cut-off value, the sensitivity, specificity and accuracy for prediction of pNETs G3/pNECs from G1/G2 were 90.91% [58.70% to 99.80%], 67.64% [48.61% to 83.32%] and 85.78% [74.14% to 97.42%], respectively. Taking rAUC below 0.855 as the optimal cut-off value, the sensitivity, specificity and accuracy for prediction of pNETs G3/pNECs from G1/G2 were 90.91% [66.26% to 99.53%], 83.87% [67.37% to 92.91%] and 94.72% [88.30% to 100.00%], respectively. Conclusions: Dynamic contrast-enhanced ultrasound analysis might be helpful for predicting the pathological grades of pNETs. Among all quantitative parameters, rPE, rmTT and rAUC are potentially useful parameters for predicting G3/pNECs with aggressive behavior.
format Online
Article
Text
id pubmed-9858178
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98581782023-01-21 Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis Yang, Dao-Hui Cheng, Juan Tian, Xiao-Fan Zhang, Qi Yu, Ling-Yun Qiu, Yi-Jie Lu, Xiu-Yun Lou, Wen-Hui Dong, Yi Wang, Wen-Ping Diagnostics (Basel) Article Objective: To investigate whether the dynamic contrast-enhanced ultrasound (DCE-US) analysis and quantitative parameters could be helpful for predicting histopathologic grades of pancreatic neuroendocrine tumors (pNETs). Methods: This retrospective study conducted a comprehensive review of the CEUS database between March 2017 and November 2021 in Zhongshan Hospital, Fudan University. Ultrasound examinations were performed by an ACUSON Sequioa unit equipped with a 3.5 MHz 6C−1 convex array transducer, and an ACUSON OXANA2 unit equipped with a 3.5 MHz 5C−1 convex array transducer. SonoVue(®) (Bracco Inc., Milan, Italy) was used for all CEUS examinations. Time intensity curves (TICs) and quantitative parameters of DCE-US were created by Vuebox(®) software (Bracco, Italy). Inclusion criteria were: patients with histopathologically proved pNETs, patients who underwent pancreatic B-mode ultrasounds (BMUS) and CEUS scans one week before surgery or biopsy and had DCE-US imaging documented for more than 2 min, patients with solid or predominantly solid lesions and patients with definite diagnosis of histopathological grades of pNETs. Based on their prognosis, patients were categorized into two groups: pNETs G1/G2 group and pNETs G3/pNECs group. Results: A total of 42 patients who underwent surgery (n = 38) or biopsy (n = 4) and had histopathologically confirmed pNETs were included. According to the WHO 2019 criteria, all pNETs were classified into grade 1 (G1, n = 10), grade 2 (G2, n = 21), or grade 3 (G3)/pancreatic neuroendocrine carcinomas (pNECs) (n = 11), based on the Ki−67 proliferation index and the mitotic activity. The majority of the TICs (27/31) of pNETs G1/G2 were above or equal to those of pancreatic parenchyma in the arterial phase, but most (7/11) pNETs G3/pNECs had TICs below those of pancreatic parenchyma from arterial phase to late phase (p < 0.05). Among all the CEUS quantitative parameters of DCE-US, values of relative rise time (rPE), relative mean transit time (rmTT) and relative area under the curve (rAUC) were significantly higher in pNETs G1/G2 group than those in pNETs G3/pNECs group (p < 0.05). Taking an rPE below 1.09 as the optimal cut-off value, the sensitivity, specificity and accuracy for prediction of pNETs G3/pNECs from G1/G2 were 90.91% [58.70% to 99.80%], 67.64% [48.61% to 83.32%] and 85.78% [74.14% to 97.42%], respectively. Taking rAUC below 0.855 as the optimal cut-off value, the sensitivity, specificity and accuracy for prediction of pNETs G3/pNECs from G1/G2 were 90.91% [66.26% to 99.53%], 83.87% [67.37% to 92.91%] and 94.72% [88.30% to 100.00%], respectively. Conclusions: Dynamic contrast-enhanced ultrasound analysis might be helpful for predicting the pathological grades of pNETs. Among all quantitative parameters, rPE, rmTT and rAUC are potentially useful parameters for predicting G3/pNECs with aggressive behavior. MDPI 2023-01-09 /pmc/articles/PMC9858178/ /pubmed/36673048 http://dx.doi.org/10.3390/diagnostics13020238 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yang, Dao-Hui
Cheng, Juan
Tian, Xiao-Fan
Zhang, Qi
Yu, Ling-Yun
Qiu, Yi-Jie
Lu, Xiu-Yun
Lou, Wen-Hui
Dong, Yi
Wang, Wen-Ping
Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis
title Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis
title_full Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis
title_fullStr Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis
title_full_unstemmed Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis
title_short Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis
title_sort prediction of pathological grades of pancreatic neuroendocrine tumors based on dynamic contrast-enhanced ultrasound quantitative analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858178/
https://www.ncbi.nlm.nih.gov/pubmed/36673048
http://dx.doi.org/10.3390/diagnostics13020238
work_keys_str_mv AT yangdaohui predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT chengjuan predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT tianxiaofan predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT zhangqi predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT yulingyun predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT qiuyijie predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT luxiuyun predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT louwenhui predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT dongyi predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis
AT wangwenping predictionofpathologicalgradesofpancreaticneuroendocrinetumorsbasedondynamiccontrastenhancedultrasoundquantitativeanalysis